院外心脏骤停成年幸存者神经认知筛查工具测量质量与可行性的系统评价
该系统评价检索MEDLINE、EMBASE、CENTRAL、CINAHL、PsychINFO(自建库至2024年8月23日),纳入评估院外心脏骤停幸存者多域神经认知筛查工具测量性能、可解释性和可行性的研究,共纳入27篇文章,涉及13种工具(MoCA、T-MoCA、Mini MoCA、MMSE、MMSE-ALFI、3MS、TICS、TICS-m、WASI、IQCODE、IQCODE-CA、SF-16 IQCODE-CA和CFQ)。仅MoCA和IQCODE-CA两种工具有测量性能报告:MoCA在两项研究中显示高质量效标效度证据(汇总AUC 0.80,95%CI 0.67–0.93),IQCODE-CA结果不一致;所有13种工具的可解释性和可行性证据有限。结论认为必需测量性能证据不足限制了工具选择,MoCA效标效度可接受但内容效度证据不充分,信度和反应度缺乏。
要点
- 该系统评价共纳入27篇文章,涉及13种神经认知筛查工具,仅MoCA和IQCODE-CA两种工具有测量性能报告。
- MoCA在两项研究中显示高质量效标效度证据,汇总AUC为0.80(95%CI 0.67–0.93)。
- IQCODE-CA的测量性能结果不一致。
- 所有13种工具的可解释性和可行性证据均有限。
- MoCA内容效度证据不充分,信度和反应度证据缺乏。
适用人群与场景
- 院外心脏骤停成年幸存者。
研究设计与关键结果
- 研究类型为系统评价,检索MEDLINE、EMBASE、CENTRAL、CINAHL、PsychINFO自建库至2024年8月23日,共筛查2336篇标题和摘要,最终纳入27篇文章,涉及13种工具(MoCA、T-MoCA、Mini MoCA、MMSE、MMSE-ALFI、3MS、TICS、TICS-m、WASI、IQCODE、IQCODE-CA、SF-16 IQCODE-CA和CFQ)。
- 仅MoCA和IQCODE-CA两种工具有测量性能报告;MoCA在两项研究中显示高质量效标效度证据,汇总AUC为0.80(95%CI 0.67–0.93)。
- IQCODE-CA的测量性能结果不一致;所有13种工具的可解释性和可行性证据均有限。
- 结论认为必需测量性能证据不足限制工具选择;MoCA效标效度可接受,但内容效度证据不充分,信度和反应度缺乏。
证据类型、等级与局限
- 证据类型为系统评价,按照COSMIN指南进行证据评价,采用GRADE标准评级证据确定性。
- MoCA效标效度证据质量为高质量;IQCODE-CA结果不一致;所有工具的可解释性和可行性证据有限。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出,必需测量性能证据不足限制了工具选择;MoCA效标效度可接受但内容效度证据不充分,信度和反应度缺乏。
- 原文结论认为应优先建立 robust 证据以指导该人群神经认知功能筛查。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To systematically review and appraise the measurement properties, interpretability, and feasibility of outcome measurement instruments (OMIs) for screening neurocognitive function among adult survivors of out-of hospital cardiac arrest (OHCA).
METHODS: Online databases were searched (MEDLINE, EMBASE, CENTRAL, CINAHL, PsychINFO) from inception - August 23, 2024. Included articles evaluated measurement properties, interpretability (assigning meaning to scores), and/or feasibility (ease of application) of multidomain instruments for screening neurocognitive function among OHCA survivors. Evidence was reviewed according to the Consensus-based Standards for the selection of health status Measurement Instruments (COSMIN) guidelines: Risk of Bias determined study quality; COSMIN criteria for good measurement properties was applied; data were pooled where possible, finally, the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria rated the certainty of evidence.
RESULTS: Of 2336 titles and abstracts, 27 articles provided evidence for 13 instruments (MoCA, T-MoCA, Mini MoCA, MMSE, MMSE-ALFI, 3MS, TICS, TICS-m, WASI, IQCODE, IQCODE-CA, SF-16 IQCODE-CA, and CFQ). Only three reported measurement properties for two OMIs: the MoCA and the IQCODE-CA. The MoCA demonstrated high quality evidence of criterion validity across two studies (pooled AUC: 0.80; 95% CI: 0.67 to 0.93). There were inconsistent results for the IQCODE-CA. There was limited evidence of score interpretability and feasibility across all 13 OMIs.
CONCLUSIONS: Insufficient evidence of essential measurement properties limits instrument choice. Whilst the MoCA had acceptable criterion validity, evidence of content validity was inadequate, and reliability and responsiveness lacking. Establishing robust evidence to inform screening of neurocognitive function in this population should be prioritized.
参考来源
- Aves T, Allan KS, Sujanthan S, et al. Evaluating measurement quality and feasibility of neurocognitive screening instruments for adult survivors of out-of-hospital cardiac arrest: A systematic review. Resuscitation. 2025. PMID: 40889586. doi:10.1016/j.resuscitation.2025.110793
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。